T-cell-receptor engagement and tumor ICAM-1 up-regulation are required to by-pass low susceptibility of melanoma cells to autologous CTL-mediated lysis
✍ Scribed by Andrea Anichini; Roberta Mortarini; Giorgio Parmiani; Saverio Alberti; Alberto Mantovani
- Book ID
- 102867887
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- French
- Weight
- 955 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Tumor‐specific and non‐specific CD3^+^, TcRαβ^+^, CD8^+^ cytotoxic T‐cell (CTL) clones, isolated from tumor‐infiltrating lymphocytes (TIL) or peripheral blood lymphocytes (PBL) of a melanoma patient and allogeneic LAK cells, were used to investigate the requirements for bypassing the low lysability of some melanoma clones derived from an S.C. metastasis from which highly lysable clones were also obtained. Cytofluorimetric analysis showed that all melanoma clones expressed ICAM‐1, although to different extents, reaching a 10‐fold difference in fluorescence units, while HLA class‐1 antigens were similarly expressed. The differences in expression of ICAM‐1 among tumor clones correlated with differences in lysability, by both specific and non‐specific CTL, but were not large enough to affect lymphocyte‐tumor conjugate formation. Cytokine‐ or gene‐transfer‐mediated up‐regulation of ICAM‐1 did not induce de novo lysis of ICAM‐1^low^ tumor cells; however, it markedly enhanced a low level of killing of the same cells by tumor‐specific, TcR‐dependent and HLA‐restricted CTL clones but not by non‐specific, TcR‐independent effectors. In addition, lysis of melanoma clones by any effector was similarly inhibited by anti‐ICAM‐1 and anti‐LFA‐1 antibodies. This indicates that by‐pass of low lysability of ICAM‐1^low^ melanoma clones by CTL clones, after ICAM‐1 up‐regulation, is possible only if simultaneous LFA‐1 and TcR engagement takes place. In addition, these results suggest that the constitutive high level of expression of ICAM‐1 on the subset of ICAM‐1^high^ melanoma cells must be only one of the factors contributing to the high lysability of these cells by any effector.